Cardiopulmonary exercise testing provides a predictive tool for early and late outcomes in abdominal aortic aneurysm patients

Abstract

CPET provided the only means in this study of predicting both 30-day outcome and 30-month mortality. CPET could therefore become an increasingly important tool in determining the optimum management for AAA patients.

Prediction of organ‐specific complications following abdominal aortic aneurysm repair using cardiopulmonary exercise testing

“…Previous studies have demonstrated that CPET variables predict short-and mid-term mortality in patients undergoing elective AAA repair [12,20,21]. In this study, postoperative 30-day mortality was not predicted by CPET variables.…”

Preoperative cardiopulmonary exercise testing and risk of early mortality following abdominal aortic aneurysm repair8

“…The association between AT and early mortality has been demonstrated previously in major non‐cardiac surgery5–7. Although patients undergoing open AAA repair were included in these investigations, the three small studies that have looked specifically at patients undergoing AAA repair to date failed to demonstrate this association14–16.…”

“…The evidence base supporting the value of preoperative CPET in identifying high‐risk patients undergoing major non‐cardiac surgery is increasing5–13. In patients undergoing AAA repair there remains no consensus on the role of CPET in elective AAA repair14–16. The objective of this study was to evaluate whether preoperative CPET‐derived variables are useful in the prediction of early mortality in patients undergoing elective open and endovascular (EVAR) AAA repair.…”

2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

“…Most studies were small, were conducted at a single center, and reflect variations in patient populations, types of surgery, and management. [67][68][69] Arrhythmogenic Right Ventricular (RV) Cardiomyopathy and/or Dysplasia: In 1 autopsy study examining a series of 200 cases of sudden death associated with arrhythmogenic RV cardiomyopathy and/or dysplasia, death occurred in 9.5% of cases during the perioperative period. 70 This emphasizes the importance of close perioperative evaluation and monitoring of these patients for ventricular arrhythmia.…”